Autologous dendritic cell vaccines for non-small-cell lung cancer.

PubWeight™: 1.18‹?› | Rank: Top 10%

🔗 View Article (PMID 15254048)

Published in J Clin Oncol on July 15, 2004

Authors

Edward A Hirschowitz1, Terry Foody, Richard Kryscio, Larry Dickson, Jamie Sturgill, John Yannelli

Author Affiliations

1: Division of Pulmonary and Critical Care Medicine, University of Kentucky, Chandler Medical Center, 800 Rose Street, Room MN 614, Lexington, KY 40536, USA. eahirs2@pop.uky.edu

Associated clinical trials:

Lung Cancer Vaccine Plus Oral Dietary Supplement | NCT01829373

Allogeneic Cellular Vaccine 1650-G for Non-Small Cell Lung Cancer | NCT00654030

Articles citing this

Caspase-dependent immunogenicity of doxorubicin-induced tumor cell death. J Exp Med (2005) 4.32

Trial watch: Dendritic cell-based interventions for cancer therapy. Oncoimmunology (2012) 1.51

Strategies for cancer vaccine development. J Biomed Biotechnol (2010) 1.26

Lung cancer immunotherapy. Clin Med Res (2005) 1.04

Immunization of NSCLC patients with antigen-pulsed immature autologous dendritic cells. Lung Cancer (2007) 1.03

Immunotherapy with allotumour mRNA-transfected dendritic cells in androgen-resistant prostate cancer patients. Br J Cancer (2005) 1.00

Active-specific immunotherapy for non-small cell lung cancer. J Thorac Dis (2011) 0.99

A disintegrin and metalloproteinase 10 regulates antibody production and maintenance of lymphoid architecture. J Immunol (2011) 0.90

Lung cancer: a classic example of tumor escape and progression while providing opportunities for immunological intervention. Clin Dev Immunol (2012) 0.89

Targeting the immune system in non-small-cell lung cancer: bridging the gap between promising concept and therapeutic reality. Clin Lung Cancer (2010) 0.88

Survivin: A molecular biomarker in cancer. Indian J Med Res (2015) 0.86

Mature autologous dendritic cell vaccines in advanced non-small cell lung cancer: a phase I pilot study. J Exp Clin Cancer Res (2011) 0.86

Improvement of DC vaccine with ALA-PDT induced immunogenic apoptotic cells for skin squamous cell carcinoma. Oncotarget (2015) 0.86

Immunotherapy prospects in the treatment of lung cancer and mesothelioma. Transl Lung Cancer Res (2014) 0.85

Lung cancer vaccines. Cancer J (2011) 0.82

Dendritic Cell (DC) Vaccine in Mouse Lung Cancer Minimal Residual Model; Comparison of Monocyte-derived DC vs. Hematopoietic Stem Cell Derived-DC. Immune Netw (2012) 0.79

Generation of dendritic cell-based vaccine using high hydrostatic pressure for non-small cell lung cancer immunotherapy. PLoS One (2017) 0.77

Deconvolution of the gene expression profiles of valuable banked blood specimens for studying the prognostic values of altered peripheral immune cell proportions in cancer patients. PLoS One (2014) 0.76

Respiratory Homeostasis and Exploitation of the Immune System for Lung Cancer Vaccines. US Oncol (2009) 0.75

Immune response and long-term clinical outcome in advanced melanoma patients vaccinated with tumor-mRNA-transfected dendritic cells. Oncoimmunology (2016) 0.75

Cancer targeting vaccines: surrogate measures of activity. Hum Vaccin Immunother (2013) 0.75

Calreticulin is an effective immunologic adjuvant to tumor-associated antigens. Exp Ther Med (2017) 0.75

Articles by these authors

Improvement of bilateral motor functions in patients with Parkinson disease through the unilateral intraputaminal infusion of glial cell line-derived neurotrophic factor. J Neurosurg (2005) 2.53

ADAM10 is a principal 'sheddase' of the low-affinity immunoglobulin E receptor CD23. Nat Immunol (2006) 1.83

Comparing functional profiles of children with hemiplegic and diplegic cerebral palsy in GMFCS Levels I and II: Are separate classifications needed? Dev Med Child Neurol (2006) 1.59

Systemic metabolic effects of combined insulin-like growth factor-I and growth hormone therapy in patients who have sustained acute traumatic brain injury. J Neurosurg (2006) 1.43

Outcome assessments in children with cerebral palsy, part I: descriptive characteristics of GMFCS Levels I to III. Dev Med Child Neurol (2007) 1.40

Unilateral intraputamenal glial cell line-derived neurotrophic factor in patients with Parkinson disease: response to 1 year of treatment and 1 year of withdrawal. J Neurosurg (2007) 1.34

Outcome assessments in children with cerebral palsy, part II: discriminatory ability of outcome tools. Dev Med Child Neurol (2007) 1.12

Autoantibodies to amyloid beta-peptide (Abeta) are increased in Alzheimer's disease patients and Abeta antibodies can enhance Abeta neurotoxicity: implications for disease pathogenesis and vaccine development. Neuromolecular Med (2003) 1.11

Toll-like receptor expression and activation in astroglia: differential regulation by HIV-1 Tat, gp120, and morphine. Immunol Invest (2011) 1.04

Immunization of NSCLC patients with antigen-pulsed immature autologous dendritic cells. Lung Cancer (2007) 1.03

Dosing and safety of cyclosporine in patients with severe brain injury. J Neurosurg (2008) 1.00

Dysregulation of leptin signaling in Alzheimer disease: evidence for neuronal leptin resistance. J Neurochem (2013) 1.00

Impact of body mass index on treatment outcomes in endometrial cancer patients receiving doxorubicin and cisplatin: a Gynecologic Oncology Group study. Gynecol Oncol (2006) 0.99

Rating the severity of ALS by caregivers over the telephone using the ALSFRS-R. Amyotroph Lateral Scler Other Motor Neuron Disord (2005) 0.98

Calcium transient evoked by TRPV1 activators is enhanced by tumor necrosis factor-{alpha} in rat pulmonary sensory neurons. Am J Physiol Lung Cell Mol Physiol (2010) 0.97

Epoxyeicosatrienoic acids are involved in the C(70) fullerene derivative-induced control of allergic asthma. J Allergy Clin Immunol (2012) 0.95

CERAD practice effects and attrition bias in a dementia prevention trial. Int Psychogeriatr (2013) 0.95

Unilateral intraputaminal glial cell line-derived neurotrophic factor in patients with Parkinson disease: response to 1 year each of treatment and withdrawal. Neurosurg Focus (2006) 0.94

Decreased low back pain intensity and differential gene expression following Calmare®: results from a double-blinded randomized sham-controlled study. Res Nurs Health (2015) 0.88

Neurologic complications of bladder carcinoma: a review of 359 cases. Cancer (2003) 0.87

Myeloid-derived suppressor cells enhance IgE-mediated mast cell responses. J Leukoc Biol (2013) 0.86

Pulmonary chemoreflex responses are potentiated by tumor necrosis factor-alpha in mice. J Appl Physiol (1985) (2013) 0.85

Joint modeling of longitudinal data in multiple behavioral change. Eval Health Prof (2010) 0.85

Factors relating to patient visit time with a physician. Med Decis Making (2011) 0.84

Characteristics of PBMC obtained from leukapheresis products and tumor biopsies of patients with non-small cell lung cancer. Oncol Rep (2009) 0.82

Research on Parkinson disease. J Neurosurg (2005) 0.79

Obstructive sleep apnea-hypopnea results in significant variations in cerebral hemodynamics detected by diffuse optical spectroscopies. Physiol Meas (2014) 0.79

Statewide systematic evaluation of sudden, unexpected infant death classification: results from a national pilot project. Matern Child Health J (2010) 0.78

Quality of education and memory test performance in older men: the New York University Paragraph Recall Test normative data. Curr Alzheimer Res (2013) 0.78

Creative musical expression as a catalyst for quality-of-life improvement in inner-city adolescents placed in a court-referred residential treatment program. Adv Mind Body Med (2009) 0.78

The large scale generation of dendritic cells for the immunization of patients with non-small cell lung cancer (NSCLC). Lung Cancer (2005) 0.78

Nature throws curveballs: APOE and nonlinear decline in Alzheimer disease. Neurology (2005) 0.77

Acute Low Back Pain: Differential Somatosensory Function and Gene Expression Compared With Healthy No-Pain Controls. Clin J Pain (2016) 0.77

Electromagnetic field treatment of nerve crush injury in a rat model: effect of signal configuration on functional recovery. Bioelectromagnetics (2007) 0.77

Contribution of BRCA1 and BRCA2 to familial ovarian cancer: a gynecologic oncology group study. Gynecol Oncol (2002) 0.77

Regulation of the IgE response. F1000 Biol Rep (2010) 0.77

Depressive symptoms and cytokine levels in Serum and Tumor Tissue in patients with an Astrocytoma: a pilot study. BMC Res Notes (2014) 0.76

Author Response. Neurology (2015) 0.75

How many HITS are too many?: The use of accelerometers to study sports-related concussion. Neurology (2012) 0.75

Comparison of outcomes of group O vs non-group O premature neonates receiving group O RBC transfusions. Am J Clin Pathol (2013) 0.75

Pedobarographic changes in Ponseti-treated clubfeet with and without anterior tibialis tendon transfer: changes due to growth and surgical intervention. J Pediatr Orthop B (2016) 0.75

900 Effect of Cyclosporin A Therapy on Functional Outcome in Severe Traumatic Brain Injury: Report of a Phase I/II Clinical Trial. Neurosurgery (2005) 0.75

Circulating Lipids and Acute Pain Sensitization: An Exploratory Analysis. Nurs Res (2017) 0.75